Skip to content

Clinical trials

Observational Pulmonary Embolism trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Observational Country / region: Switzerland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20141
20151
20161
20182
20203
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern2
Ottawa Hospital Research Institute2
University Hospital, Geneva2
Boston Scientific Corporation1
Inari Medical1
Penumbra Inc.1
Salah D. Qanadli1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism11
Venous Thrombosis4
Thromboembolism3
Venous Thromboembolism3
Atrial Fibrillation1
COVID-191
Embolism and Thrombosis1
Iatrogenic Disease1
Mobility Limitation1
Pneumonia, Viral1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.